IDXX Q1 2021 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$778M+24.2% YoY

Gross Profit

$471M60.5% margin

Operating Income

$248M31.8% margin

Net Income

$204M26.3% margin

EPS (Diluted)

$2.35

QoQ Revenue Growth

+7.9%

Cash Flow

Operating Cash Flow

$124M

Free Cash Flow

$104M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.6B

Stockholders' Equity

$703M

Cash & Equivalents

$351M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$778M	$626M	+24.2%
Gross Profit	$471M	$360M	+30.9%
Operating Income	$248M	$144M	+71.6%
Net Income	$204M	$112M	+82.7%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$2.3B97%

Reagent Rental Programs

$38M2%

Extended Warranties And Post Contract Support

$19M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$473M61%

EMEA

$171M22%

Asia Pacific

$85M11%

CANADA

$33M4%

Latin America

$16M2%